Clinical Trial Update: Optimizing Hydroxyurea Therapy in Children With SCA In Malaria Endemic Areas [Phase 3]

View source ↗

Summary

Phase 3 trial updating hydroxyurea therapy in children with sickle cell disease in malaria-endemic areas has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria
• Sickle Cell Disease

Drugs mentioned

• HYDROXYUREA (Hydroxyurea)

Snippet

Sponsor: Indiana University | Conditions: Sickle Cell Anemia, Sickle Cell Disease | Phase 3 | Status: COMPLETED